本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Edgewise Therapeutics, Inc.

15.75
+0.30001.94%
盘后15.750.00000.00%16:20 EDT
成交量:112.85万
成交额:1,790.20万
市值:16.57亿
市盈率:-10.17
高:16.30
开:15.64
低:15.30
收:15.45
数据加载中...
2023/06/22

重要事件披露

Form 8-K - Current report
2023/06/17

重要事件披露

Form 8-K - Current report
2023/06/12

重要事件披露

Form 8-K - Current report
2023/05/11

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/05/11

重要事件披露

8-K - Current report
2023/05/11

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/03/06

重要事件披露

8-K - Current report
2023/02/23

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/23

重要事件披露

8-K - Current report
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/01

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/11/03

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/11/03

重要事件披露

8-K - Current report
2022/09/30

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/26

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/09/23

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/09/16

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership